Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma
Richard J. Lin, Stephanie Lobaugh, Martina Pennisi, Hei Ton Chan, Yakup Batlevi, Josel D. Ruiz, Theresa A. Elko, Molly Maloy, Connie Lee Batlevi, Parastoo B. Dahi, Sergio Giralt, Paul A. Hamlin, Elena Mead, Arela Noy, M. Lia Palomba, Bianca Santomasso, Craig S. Sauter, Michael Scordo, Gunjan L. Shah, Beatriz Korc‐Grodzicki, Soo‐Jeong Kim, Mari Lynne Silverberg, Chelsea Brooklyn, Sean M. Devlin, Miguel‐Angel Perales
Abstract
Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed
Topics & Concepts
Chimeric antigen receptorLymphomaMedicineRefractory (planetary science)AntigenOncologyCell therapyInternal medicineReceptorImmunologyCellImmunotherapyCancerBiologyAstrobiologyGeneticsCAR-T cell therapy researchIntegrated Circuits and Semiconductor Failure Analysis